CD8A and COVID-19: However, in the current study, as a consequence of reduced oxygenation due to COVID-19 lung dysfunction, both CD8+TM and their upstream effector precursors were found to be phenotypically and functionally glycolytic, suggesting a metabolically linked impairment in CD8+TM function and differentiation.